Glen Harbor Capital Management’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$535K Hold
15,428
0.01% 679
2019
Q2
$489K Buy
15,428
+2,632
+21% +$78.2K 0.01% 713
2019
Q1
$383K Buy
12,796
+2,464
+24% +$70.6K 0.01% 769
2018
Q4
$319K Hold
10,332
0.01% 783
2018
Q3
$392K Sell
10,332
-45,276
-81% -$1.71M 0.01% 817
2018
Q2
$2.13M Buy
55,608
+13,468
+32% +$454K 0.05% 312
2018
Q1
$1.42M Buy
42,140
+30,856
+273% +$1.18M 0.03% 343
2017
Q4
$501K Sell
11,284
-1,008
-8% -$45.9K 0.01% 643
2017
Q3
$616K Buy
12,292
+1,456
+13% +$74.4K 0.01% 534
2017
Q2
$572K Buy
10,836
+504
+5% +$27K 0.01% 556
2017
Q1
$574K Buy
10,332
+420
+4% +$23.2K 0.01% 522
2016
Q4
$516K Buy
+9,912
New +$478K 0.01% 488

Other funds holding PBH

Glen Harbor Capital Management's PBH Position: Q3 2019 in Review

Glen Harbor Capital Management held its Prestige Consumer Healthcare (PBH) position steady in Q3 2019 at 15,428 shares worth $535K. The position accounts for 0.01% of the portfolio, ranked #679.

Glen Harbor Capital Management first reported a position in PBH in Q4 2016 and has held it in 12 quarters since. The position peaked at $2.13M in Q2 2018. 230 funds tracked by Wall St. Rank hold PBH as of Q3 2019.

  • Glen Harbor Capital Management held 15,428 shares of Prestige Consumer Healthcare worth $535K as of Q3 2019.
  • Glen Harbor Capital Management left its Prestige Consumer Healthcare share count unchanged in Q3 2019.
  • Prestige Consumer Healthcare made up 0.01% of Glen Harbor Capital Management's portfolio in Q3 2019, its #679 holding.
  • Glen Harbor Capital Management first reported a position in Prestige Consumer Healthcare in Q4 2016 and has held it in 12 quarters since.
  • Glen Harbor Capital Management's Prestige Consumer Healthcare position peaked at $2.13M in Q2 2018.
  • 230 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q3 2019.

Based on Glen Harbor Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.